Skip to main content
MSKCC Education and Training
  • Calendar
  • More
You are currently using guest access
Log in
MSKCC Education and Training
Calendar
Expand all Collapse all
  1. Dashboard
  2. GI Med Onc
  3. Module 4: Pancreatic, Ductal, and Adenocarcinoma
  4. Required Reading

Required Reading

Completion requirements
    • Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.pdf Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.pdf
    • NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma NAPOLI 3 a randomised, open-label, phase 3 trial.pdf NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma NAPOLI 3 a randomised, open-label, phase 3 trial.pdf
    • Pancreatic cancer ESMO Clinical Practice Guideline for diagnosis treatment and follow up.pdf Pancreatic cancer ESMO Clinical Practice Guideline for diagnosis treatment and follow up.pdf
Contact site support
You are currently using guest access (Log in)
Get the mobile app
Powered by Moodle Workplace™